UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by J. Safra Sarasin Holding AG

J. Safra Sarasin Holding AG grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 20.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 18,406 shares of the healthcare conglomerate’s stock after buying an additional 3,163 shares during the period. J. Safra Sarasin Holding AG’s holdings in UnitedHealth Group were worth $9,311,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently modified their holdings of UNH. Norges Bank purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $6,375,744,000. Raymond James Financial Inc. purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $1,914,740,000. Amundi raised its stake in UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC boosted its position in UnitedHealth Group by 76,830.4% during the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after acquiring an additional 1,886,186 shares during the last quarter. Finally, Capital International Investors boosted its stake in UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after buying an additional 906,365 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on UNH. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday. Barclays cut their price target on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a report on Monday. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Truist Financial decreased their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research report on Monday. Finally, KeyCorp decreased their target price on UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research report on Monday. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and four have given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $615.24.

View Our Latest Analysis on UNH

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $425.39 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $424.81 and a 52 week high of $630.73. The firm’s 50 day moving average is $510.91 and its two-hundred day moving average is $538.77. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $389.11 billion, a P/E ratio of 27.44, a PEG ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the company earned $6.91 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.97%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.18%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.